A Deep Dive Into FDA’s Approval of First OTC Birth Control Pill
Image Credit: Adobe Stock Images/9DreamStudio.com In 2023, the FDA approved the first over-the-counter (OTC) birth control pill for use in…
Category: Medicine
Communicating the Value of Approved Therapies
In a video interview with Pharma Commerce, Derrick Gastineau, head of marketing with Currax Pharmaceuticals, emphasizes the importance of pricing…
Oral Weight Loss Treatments Offer Patients and Clinicians New Options in Obesity Care
In a video interview with Pharma Commerce, Derrick Gastineau, head of marketing with Currax Pharmaceuticals, emphasizes the importance of pricing…
New Phononic–Peltier Partnership Targets Safer, Smarter Cold Chain for Medicines
Image Credit: Adobe Stock Images/DragoDesigner.com Phononic, a company that specializes cooling technology, including for the pharma sector, has reached a…
Ascensia to Transfer Eversense CGM Commercial Operations to Senseonics
Image Credit: Adobe Stock Images/Jordi.com Ascensia Diabetes Care—a part of PHC Group—has signed a memorandum of understanding (MOU) to transfer…
What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients
Ned Milenkovich, PharmD, JD The Most Favored Nation Mandate: What the President’s Drug Pricing Push Means for Pharma, Payers, and…
Samsung Biologics Secures $1.3B US Manufacturing Deal Amidst Tariff Uncertainty
Image Credit: Adobe Stock Images/Wichayada.com According to FirstWord Pharma, Samsung Biologics, a contract development and manufacturing organization (CDMO) based in…
DHL Supply Chain Acquires SDS Rx, Expanding Last-Mile Healthcare Logistics
Mark Kunar of DHL Supply Chain North America (left) and Drew Kronick of SDS Rx (right). Image Credit: DHL Supply…
Consistent Cash-Pay Options Could Transform Access to Obesity Medications
In a video interview with Pharma Commerce, Derrick Gastineau, Head of Marketing with Currax Pharmaceuticals, emphasizes the importance of pricing…
White House Eyes China Drug Restrictions, Pfizer-BioNTech Vaccine Data Strong, and Samsung Biologics Secures US Deal
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Harnessing Tech to Build Resilient Hospital Supply Chains
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In…
Measles Outbreak Spurs Vaccine Mandate Debate, Trump Eyes DTC Ad Restrictions, and ICER Reviews GLP-1 Costs
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
ICER Releases Cost Analysis Report on Obesity Treatments Semaglutide, Tirzepatide
Image Credit: Adobe Stock Images/Enigma Topline Findings Significant Weight Loss Achieved: Zepbound delivers 17.8%–20.8% average weight loss, while injectable Wegovy…
Novartis Expands Cardiovascular Pipeline, Flu Severity Drivers Identified in Seniors, and Fixing Medication Nonadherence
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Hospitals Weigh ROI of RFID and RTLS for Smarter Medication Management
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In…
FDA Blocks Compounded GLP-1 Ingredients, RSV Vaccination Benefits Seniors, and Pharmacies Struggle With Pricing Program
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Transforming Hospital Pharmacy Inventory Management
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In…
Gilead Expands R&D Hub, WHO Adds GLP-1s to Essential Medicines List, and High-Dose Flu Vaccine Shows Heart Benefits
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Amgen Invests $600M in Innovation Hub, Novartis Collaborates With Argo, and Wegovy Tops Tirzepatide in Heart Outcomes
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
AI’s New Role in Pharma Strategy
Avinob Roy, Vice President & General Manager of Global Commercial Product Offerings at IQVIA, spoke with Pharmaceutical Commerce about how…
Trump Appeals Tariff Ruling, Sanofi Shares Slide on Trial Miss, and COVID-19 Alters Pneumococcal Mortality
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Gilead Breaks Ground on Technical Development Hub to Drive US Biopharma Innovation
Image Credit: Adobe Stock Images/SundryPhotography.com Gilead Sciences has unveiled its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC),…
How Drug Shortages Could Disrupt Hospital Operations and Strain Patient Care
Drug shortages continue to create significant financial and operational strain on hospitals, impacting both patient care and workforce efficiency. In…
Trump Pushes Supreme Court to Save Tariffs After Appeals Court Ruling Limits Presidential Power
Image Credit: Adobe Stock Images/Philip.com Last night, the Trump administration requested that the US Supreme Court hear out an appeal…
Overcoming Barriers to Full e-Prescribing Adoption
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because…
Amgen to Invest $600M in New Science and Innovation Center at California HQ
Image Credit: Adobe Stock Images/MichaelVi.com Amgen will be financially committing upwards of $600 million into a new, state-of-the-art, science and innovation center at…
Why Reducing Paper Inserts Is About Access as Much as Sustainability
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because…
Modernizing Prescription Information
The Prescription Information Modernization Act of 2025 (PIMA) is being hailed as a significant development for the pharmaceutical industry because…
Moving from Omnichannel to Optichannel Engagement Strategies: Your Questions Answered
Life science marketing is changing. Practices which worked for the blockbuster drug era are no longer appropriate for today’s environment…
Pharma Supply Chain Faces Risks of Tariffs Driving Excess Inventory
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a…
Child Vaccines Show Adult Protection, Lilly Pauses Mounjaro Shipments, and FDA Rejects Lytenava Resubmission
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
ACOG Reaffirms COVID-19 Vaccine in Pregnancy, SGLT2 Real-World Safety Data, and EVERSANA–Waltz Tackle Drug Costs
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Cold Chain Technologies Expands APAC Presence With New Hubs, Distributors, and Manufacturing Investment
Image Credit: Cold Chain Technologies Cold Chain Technologies (CCT), is solidifying its commitment to growing its Asia-Pacific (APAC) presence by…
CDC Director Pushback, Persistent Drug Shortages, and FDA Clears First Generic GLP-1 for Weight Loss
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Mitigating Pharmaceutical Supply Chain Challenges
Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business,…
Pharmaceutical Commerce Presents The Most Favored Nation Mandate
Pharmaceutical Commerce presents The Most Favored Nation Mandate webinar! Earlier this year, Donald Trump issued an executive order stating that…
Eli Lilly Pauses UK Mounjaro Shipments Ahead of 170% Price Hike
Image Credit: Adobe Stock Images/KKStock.com With an increase in price forthcoming, Eli Lilly has decided to temporarily pause UK shipments…
Balancing Tariffs and Patient Access in Pharma Policy
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a…
The Great Pharma Reshoring
This video was created based on various Pharma Commerce articles: AbbVie Invests $195 Million to Expand Stateside API Manufacturing AstraZeneca…
FDA Greenlights New COVID Vaccines, Sets Eligibility Limits
Credit: Tada Images | stock.adobe.com The FDA has authorized the use of updated COVID-19 vaccines for the upcoming fall season,…
EVERSANA, Waltz Health Form Combined Platform to Tackle Drug Costs and Access Challenges
Image Credit: Adobe Stock Images/Stas_Malyarevsky.com EVERSANA, a global services provider to the life sciences sector, and Waltz Health, a digital…
AI Fuels Surge in Counterfeit Drug Websites
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication…
Novo Nordisk Plant Faces FDA Scrutiny, Off-Label GLP-1 Use Grows, and AbbVie Expands Psychiatry Pipeline
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Novo Nordisk’s Indiana Plant Flagged by FDA for Contamination and Safety Lapses
Image Credit: Adobe Stock Images/TadaImages.com Novo Nordisk has some facility issues to address. As first reported by STAT News,1 the…
Top Questions Regarding the DSCSA
Image Credit: Adobe Stock Images/DreamerStudio.com DSCSA stands for the Drug Supply Chain Security Act, and is enforced by the FDA.…
Johnson & Johnson Commits $2 Billion to North Carolina Manufacturing Expansion
Image Credit: Adobe Stock Images/MichaelVi.com Johnson & Johnson is all in on domestic manufacturing. The company announced plans to boost its…
Combating Counterfeit Medicines Requires AI Integration and Industry Collaboration
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication…
Pharma Tariffs Take Shape, J&J Invests $2 Billion in US Manufacturing, and New EHR Rule Targets Prior Authorization
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Pharma Regulatory Strategies Could Shift as Vaccine Support Declines
In a recent interview with Pharmaceutical Commerce, Ron Lanton, partner at Lanton Law, discussed the high-stakes implications of a new lawsuit…
Building the Next-Generation Supply Chain Talent Pipeline (Episode 9)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
CVS Caremark Ordered to Pay $290 Million in False Claims Act Whistleblower Case
Image Credit: Adobe Stock Images/ImagingL.com Following an eight-day bench trial, a judge has issued a final judgement ruling that pharmacy…
White House and EU Finalize Trade Deal With 15% Cap on Pharma Tariffs
Image Credit: Adobe Stock Images/Aquir.com As noted by Pharm Exec,1 the White House and European Union today revealed a framework…
What Supply Chain Leaders Need to Know About COVID Vaccine Policy Uncertainty
In a recent interview with Pharmaceutical Commerce, Ron Lanton, partner at Lanton Law, discussed the high-stakes implications of a new…
New Technologies Drive Down Pharma Manufacturing Costs in the United States
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a…
Agile Drug Manufacturing Advances, Merck–Skyhawk RNA Deal, and Telehealth Expands Pharmacists’ Role
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
AI-Powered Tools Transform Fight Against Counterfeit Drugs
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication…
Wegovy Wins Accelerated Approval, New Flu Combo Emerges, and Community Pharmacies Expand Access
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Counterfeiters Target Fragmented Pharma Supply Chains Through Digital Marketplaces
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication…
GLP-1 Access Partnership, Pfizer’s Sickle Cell Setback, and Patient Portal Trade-Offs
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
The Tariff Saga Continues
It’s been about six months since the trade wars pitting the US vs. various global nations and regions have commenced,…
A Pharma Wholesaler Scorecard
Mike Hennessy Jr, chairman and CEO, MJH Life Sciences Every stakeholder’s role in the pharmaceutical supply chain is just as…
US API Stockpile Plan, Mounjaro Price Hike in UK, and New Data on Vaccine Safety
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Goodpath Partners With GiftHealth to Expand Access to GLP-1 Therapies Through LillyDirect
Image Credit: Adobe Stock Images/Thanayut.com Goodpath, a virtual clinic for chronic health conditions, has reached a pharmacy integration deal with GiftHealth,…
Pharma Leaders Stress Tailored, Balanced Approach to Long-Term Manufacturing Strategy (Episode 8)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
Gross-to-Net Bubble Reshapes Drug Pricing Strategy
Welcome to the explainer. Today, we are talking about the wild and honestly, super complex world of drug pricing, and…
Pharmaceutical Commerce: August 2025 Interactive Digital Edition
View the Pharmaceutical Commerce August 2025 issue in an interactive format.
Pharma Wholesalers: Looking for Growth
Future Focal Points for Distributors Deepen specialty and MSO integration. Continue expanding into management service organizations and specialty care networks…
AI-Powered Counterfeit Drug Schemes Pose Growing Threat to Patient Safety
In a video interview with Pharma Commerce, Mark Lee, MarqVision’s founder and CEO, highlights the rapid growth and increasing sophistication…
Redefining the Model for Modern Pharma Marketing
Daniel J. Gandor, EVERSANA Key Takeaways True omnichannel in pharma is a unified, customer-first marketing model—not just digital or multichannel…
Potential 250% Pharma Tariffs Could Pressure Margins Without Directly Raising Patient Costs
In a video interview with Pharma Commerce, Dave Malenfant, a healthcare supply chain expert, discusses the potential impact of a…
Caveat Emptor in the Gray Market
Key Takeaways High-profile counterfeit medicine cases—from the 2019 Kentucky SURGICEL incident to counterfeit HIV drugs and Ozempic—expose vulnerabilities in the…
Insurance Barriers Delaying Patient Care
Key Takeaways Patient access to treatment remains poor. For the second year in a row, patients with chronic conditions rated…
A Rebate Double-Whammy: Exploring the Unintended Consequences
Key Takeaways GSK discontinued Flovent HFA and replaced it with a generic to avoid new Medicaid rebate rules that would…
Novo Nordisk Ramps Up Legal Fight Against Compounded Semaglutide Knockoffs
Image Credit: Adobe Stock Images/Ibnu.com Novo Nordisk recently filed 14 new lawsuits intended to protect patients from unapproved compounded drugs…
Pharma Pulse: Redefining the Pharmacy Aisle
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
Bayer Restructures, Lilly’s Oral GLP-1 Advances, and Court Ruling Shakes Up Obesity Drug Market
Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics,…
FDA Launches PreCheck Program to Strengthen US Drug Manufacturing
Image Credit: Adobe Stock Images/PostmodernStudio.com At a time when more than 50% of pharmaceuticals distributed in the United States are…
Maximizing Supply Chain Efficiency Without Overreacting to Tariffs (Episode 7)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
The Role of Digital Tools and Validation Expertise
In the highly regulated world of life sciences, compliance isn’t just a box to check; it is the foundation of…
Balancing AI Ambition With Cost Pressures in Pharma
In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big…
Tariffs Could Potentially Hit 250%
Image Credit: Adobe Stock Images/DavideBonaldo.com Last week, President Trump issued letters to 17 of the largest pharmaceutical companies, expressing dire…
Ways Pharma Supply Chains Can Cut Scope 3 Emissions Now
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks…
How Pharma Can Navigate Innovation and Cost Pressures in the GLP-1 Era
In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big…
Lessons From Shortages and Global Disruptions
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of US supply chain, describes how today’s distribution networks…
Facing a Crossroads
In a video interview with Pharma Commerce, Philip Sclafani, PwC’s pharmaceutical and life sciences lead, he describes how the One Big…
Pharma Industry Shifts Toward Full Activation
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how…
The Twin Forces Shaping Pharma Logistics Sustainability
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of…
What Clinical Ops Teams Must Know About Biomarkers in Trials; What is the Timeline for True AI Implementation for Digital Twins?
What Clinical Ops Teams Must Know About Biomarkers in Trials In an interview with Applied Clinical Trials, Michael Miller, COO…
Balancing Compliance and Supply Chain Continuity
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how…
FDA Delays Regeneron’s Odronextamab, Eylea HD Regulatory Decisions Over Catalent Site Issues
Credit: Ascannio | stock.adobe.com. The FDA has issued a second complete response letter (CRL) to Regeneron’s odronextamab based on issues…
Trump’s MFN Drug Pricing Push Targets 17 Big Pharma Companies, Spurs Global Industry Response
As reported by Pharma Commerce sister publication, Pharmaceutical Executive,1 President Trump recently issued letters to 17 of the largest pharmaceutical…
Leveraging Technology to Strengthen Pharma’s Fight Against Counterfeits (Episode 6)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
How Grocery-Based Pharmacies are Evolving into Community Health Hubs
Image Credit: Adobe Stock Images/AMuhSakaria.com As large pharmacy retailers scale back operations, community pharmacies—particularly those embedded within grocery stores—are stepping…
Emission-Reduction Strategies That Save Money and Preserve Performance
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of…
Where Has AI Already Been Successfully Implemented; How Biomarkers Are Transforming Neurology and Oncology Trials
Where Has AI Already Been Successfully Implemented? In an interview with Pharmaceutical Executive, Gen Li, president and founder of Phesi,…
Tackling ESG Data Gaps in Supplier and Third-Party Reporting
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of…
How Predictive Maintenance and Localized Distribution Are Shaping Pharma’s Future
In a video interview with Pharma Commerce, Heather Zenk, Cencora’s president of supply chain operations & distribution services, describes how…
Weighing Cost Savings Against Safety and Regulatory Risks
In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem,…
Rethinking Oncology Trials with a Statistical Methodology That Puts Patients First; How Can Real World Data and AI Help Solve Issues with Clinical Trials?
Rethinking Oncology Trials with a Statistical Methodology That Puts Patients First In an interview with Applied Clinical Trials, experts discussed…
Unlocking Sustainability Across the Supply Chain
In a video interview with Pharma Commerce, Nate Chenenko, principal with Ducker Carlisle, sheds light on the critical issue of…
Scaling Obesity Drugs Responsibly
In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem,…
Balancing DEI Reporting with Legal Risk; What the Emrelis Approval Means for Pharma and Biotech ADC Strategies
Balancing DEI Reporting with Legal Risk In an interview with Applied Clinical Trials, Kate Gallin Heffernan, a life sciences attorney…
Leveraging Digital Twins and Analytics to Optimize Global Pharma Supply Chains
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff…
How Life Sciences Firms Are Evolving to Navigate Trade, Tariff, and Pricing Turbulence
Sixty percent of life sciences and healthcare leaders are anticipating that the current or forthcoming tariffs and pricing policies will…
Supply Chain Blind Spots Threatening Pharma Integrity (Episode 5)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
Cold Chain Technologies, E&I Cooperative Services Strike Deal to Provide Schools with Expedited Access to Cold Chain Solutions
Image Credit: Adobe Stock Images/Sardar Key Takeaways Expanded Educational Access: Cold Chain Technologies (CCT) partners with E&I Cooperative Services to…
How Pharma Executives Can Prepare for Tariff Uncertainty
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff…
Driving Adherence and Safety Through Digital Innovation
Patient safety and medication adherence are some of the major concerns in the pharmaceutical industry. With an increase in medication…
Recapping the Sarepta Saga—And Implications for Industry
The controversy surrounding embattled gene therapy company Sarepta Therapeutics, including its drug, Elevidys, for Duchenne muscular dystrophy, continues to captivate…
Building Inventory and Navigating FDA Hurdles in a Tariff-Driven Market
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff…
Can Dual Agonists Deliver Better Outcomes?
In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem,…
The Ripple Effect of 200% Tariffs on US Drug Supply and Pricing
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes how a proposed 200% tariff…
Coverage Gaps and Challenges Ahead for Obesity Drugs
In a video interview with Pharma Commerce, Hyung Heon Kim, CEO of MetaVia, describes how the current US payer ecosystem,…
Balancing Awareness and Assurance
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical…
How Competition, Access, and Reimbursement Will Shape the Next Wave of Innovation
In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains…
Trump Says Pharma Industry Should Expect Tariffs by Aug. 1
President Trump noted that the pharma sector should prepare for levies by the beginning of next month, which could coincide…
The Biosimilar Void
In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains…
How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies; Eisai Explores Novel Dual Mechanism Therapy for Advanced Endometrial Carcinoma
How Parexel Supports Cross Functional Trials for Emerging GLP-1 Therapies In an interview with Applied Clinical Trials, Shipra Patel, global…
Racial, Social, and Economic Factors Drive Resilience During COVID-19 Pandemic, Study Finds
Resilience, which is the concept of defying adversity and recovering from hardship, is connected to one’s health and well-being. Image…
How DSCSA Is Transforming Supply Chain Data Exchange (Episode 4)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
The Hidden Challenge of Reporting Counterfeit Medicines
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical…
Why Medical Education Must Catch Up
In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical…
How Pharma Must Evolve in a Competitive Therapeutic Landscape
In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains…
Knipper Health Taps Willis Chandler as New President and CEO
Chandler’s pharmaceutical experience spans years in the pharma services space, powered by strategic leadership roles. Image Credit: Knipper Health Following…
From Data to Insight: Forecasting Global Medicine Use
In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains…
Gilead, Global Fund Partner to Expand Access to Lenacapavir
Gilead plans to supply enough doses to assist up to two million individuals over three years in nations supported by…
Why Every Employee Needs to Be Part of the Journey
Few times in the evolution of a pharmaceutical company are as exciting as during the flurry of launch readiness activities…
Removing Financial Barriers to Boost Trial Diversity; How Prescribing Power Has Shifted Beyond Physicians
Removing Financial Barriers to Boost Trial Diversity In an interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, emphasized…
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
Despite these medications being both available and affordable, racial, ethnic, and socioeconomic disparities came to light when it came to…
A Look Under the Hood of Medicaid Support
In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and…
How Pharma Can Detect Supply Chain Failures Before They Happen (Episode 3)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
Sustaining Regulatory Engagement Through Industry and Advocacy Collaboration
PC: In the absence of public participation at the federal level, how can industry leaders collaborate with advocacy groups to…
Reducing Healthcare Prices
In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and…
Pharma Industry Should Brace for up to 200% Tariffs
President Trump noted that import taxes on pharmaceuticals of up to 200% could come forthcoming. Image Credit: Adobe Stock Images/MohammadXte.com…
Rising Costs, Shrinking Margins
In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and…
Trump Imposes 25% Tariffs on Japan, South Korea, and a Dozen Other Nations
All of the levies come with a stipulation—if these nations increase their tariffs, the United States will raise them on…
What Payers Really Want from High Cost Therapies in Rare Diseases
PC: How might this change affect payer negotiations and reimbursement decisions, particularly for innovative or high-cost therapies? Leuchter: When it…
Aligning Real-World Evidence with Payer Perspectives
The trust gap between real-world evidence (RWE)/data and randomized controlled trials is growing. This episode examines when each evidence type…
Deepening Access Gaps
In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and…
Patient Engagement Is Critical to Developing Breakthrough Treatments
PC: What risks do you foresee for companies developing first-in-class therapies if patient perspectives are no longer formally incorporated into…
Preparing for CGT Launches
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of…
The Hidden Costs of Zero-Premium Plan Turnover
Image Credit: Adobe Stock Images/TadaImages.com As a result of the Patient Protection and Affordable Care Act (ACA), 24.2 million people…
Preparing for Federal Regulations; Funding Cuts Threaten Diversity in Clinical Research
Preparing for Federal Regulations: Q&A with John Stanford In an interview with Pharmaceutical Executive, John Stanford, executive director at Incubate,…
Novo Nordisk Expands Wegovy Access Through New WeightWatchers Partnership
Novo Nordisk is growing coverage of its Wegovy injection 2.4 mg in the form of a new deal with WeightWatchers…
Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment; How Funding Cuts Are Undermining Patient Recruitment in Clinical Trials
Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment In an interview with Pharmaceutical Executive, Biljana Naumovic, US…
The Impact of FDA’s Ban on Compounded GLP-1s; How Sites and Sponsors Are Adapting to Clinical Trial Budget Cuts
The Impact of FDA’s Ban on Compounded GLP-1s A Pharmaceutical Executive article explores how the FDA’s ban on compounded semaglutides—following…
Hikma Commits $1 Billion to Boost US Drug Manufacturing and R&D Services by 2030
This investment exemplifies Hikma’s interest in raising the volume of meds it creates and produces across its various R&D and…
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
Historically, new drugs were approved for a single therapeutic use. However, industry trends have shifted, with pharmaceutical companies increasingly identifying…
The Evolution of the CGT Launch and Distribution Model
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of…
How Patient Advocacy Is Guiding Rare Disease Drug Development
PC: What role has public participation historically played in shaping healthcare policy, and why is it important for pharma and…
Medicaid’s Role in the CGT Sector
Medicaid is especially critical for children with rare diseases, due to their need for intensive specialty care and higher risk…
Delivering Value Beyond the Trial with Real-World Evidence
Real-world evidence (RWE) is no longer optional—it’s expected. This episode dives into how payers assess RWE alongside clinical trial data,…
Leading by Example
In the fourth part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, explains the…
Supply Chain Planning in the Current CGT Climate
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of…
Overcoming Regulatory Barriers to Market Access
As international price referencing tightens and payer expectations rise, companies face a shrinking margin for error. The panel explores how…
Utilizing AI in Today’s Current Landscape
In a video interview with Pharma Commerce, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, discusses the evolving state of…
Discovering AI’s Role in Drug Safety Monitoring
Pharmaceutical Commerce: FDA staff cuts have created a critical gap in adverse drug event (ADE) monitoring. With ADEs being the…
Developing a Manufacturing Contingency Plan (Episode 2)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials; The Role of Patient Advocacy in Shaping AbbVie’s Cancer Therapies
2025 DIA Annual Meeting: How AI and Machine Learning Can Improve Patient Reported Outcomes in Clinical Trials In an interview…
Does Risk-Based Payment Drive Better Care in Medicare Advantage?
Investigators aimed to examine the quality and efficiency under the FFS MA and at-risk MA models as a way to…
How CRO Partnerships Are Evolving to Meet Changing Industry Demands; Don’t Fall for the Call of Placebo-Controlled Vaccine Trials
How CRO Partnerships Are Evolving to Meet Changing Industry Demands In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD,…
Xcellbio, Thermo Fisher Team up to Advance Cell Therapy Manufacturing
The purpose of the partnership is to help further develop the Treg and TIL cell therapies that are intended to…
The Importance of Early Patient Feedback in Digital Endpoint Development; Developing FP&A Strategies in Today’s Environment
2025 DIA Annual Meeting: The Importance of Early Patient Feedback in Digital Endpoint Development In an interview with Applied Clinical…
Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program
Stop Losing Patients at the Gate: The 24-Hour Window That Makes or Breaks Your Entire Hub Program
Building Patient Centricity into Clinical Trial Software from Day One; Industry Voices on Current Pricing and Reimbursement Models
2025 DIA Annual Meeting: Building Patient Centricity into Clinical Trial Software from Day One In an interview with Applied Clinical…
Current Perspective on Pricing and Reimbursement Models
This Peer Exchange® starts off with an introduction of the panel: Edward Ahn, CEO of MEDIPOST, Inc.; Rob Philo, Founder…
Tracking Nation’s Growth in Pharma Innovation and Global Investment; Why AI and Automation Are Set to Become the New Normal in Clinical Research
China’s Trial Advantage: Tracking Nation’s Growth in Pharma Innovation and Global Investment A recent Pharmaceutical Executive article highlights how China’s…
June 2025 Interactive Digital Edition
Pharmaceutical Commerce: June 2025 Interactive Digital Edition DSCSA Compliance: The Time is Now Conference Connect: Determining the Future of Specialty…
Strategic Planning in the Rebate Economy; The Truth About AI Adoption Speed in Clinical Research
Strategic Planning in the Rebate Economy: What Pharma Must Do Now A recent Pharmaceutical Executive article outlines how, despite decades…
Establishing Additional Transparency
In a video interview with Pharma Commerce, LeAnn Boyd, PharmD, Liviniti’s founder and CEO, discusses the deeper, systemic issues behind…
Antares Vision Group Debuts AI-Powered Visual Inspection Platform
AI-GO blister inspection. Image Credit: Antares Vision Group Antares Vision Group, a provider of track-and-trace systems for several fields including…
Understanding the Pharma Supply Chain (Episode 1)
In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the…
Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success; Innovation Requires Investment—and Sustained Investment Requires Sufficient Returns
Building Strong CRO-Sponsor Partnerships to Improve Clinical Trial Success In an interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief…
How Medicare Eligibility Affects Healthcare Use in Adults with Psychological Distress
Image Credit: Adobe Stock Images/DigitalMagicVisions.com One of several public health issues of utmost importance are mental health disorders, which are…
TekniPlex Healthcare Unveils New Barrier Protection Systems Plant
TekniPlex Healthcare, a supplier of barrier films, unit-dose containers, and more, has opened its new 200,000-square-foot facility in Madison, WI, which…
The Impact of Initial Coverage Choice
Image Credit: Adobe Stock Images/Rawpixel.com Data show that nearly two-thirds of Medicare beneficiaries feel that their coverage completely meets their…
Changing the PAP Model
The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.
Bolstering Health Technology Assessment With the Help of AI
Key Takeaways AI enhances traditional HTA by improving accuracy and efficiency. Artificial intelligence addresses key limitations of traditional health technology…
Raising the Alarm
Key Takeaways Lack of Awareness Among Healthcare Providers. Despite being the first line of defense, most HCPs receive little to…
Policy Whiplash? 24 Hours in the Hub Still Matters More
Key Takeaways Speed is Critical. The first 24 hours after a prescription are crucial—nearly half of patients are lost immediately…
What Is Smart Pharma Packaging?
In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology…
Navigating the Intersection of Accessibility and Measurement Integrity in eCOA; Do We Really Pay More for Prescription Drugs in the United States?
Navigating the Intersection of Accessibility and Measurement Integrity in eCOA An article in Applied Clinical Trials explores how clinical research’s…
Embedded Product Intelligence’s Role in Maintaining Cold Chain Integrity
In a video interview with Pharma Commerce, Kirsten Newquist, Identiv’s CEO, defines “smart pharma packaging” as the integration of technology…
Reviewing the Most-Favored Nation Model
Key Takeaways Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as…
Extreme Examples of Who Grew the Bubble
Key Takeaways Price hikes, not launch prices, drove the GTN bubble. The real driver of the gross-to-net (GTN) bubble was…
Addressing the Threat of Prescription Abandonment
Sticker shock at the pharmacy counter has become an all-too-familiar experience for both patients and providers. The rising cost of…
Financial Assistance Programs and Healthcare Plan Navigation
June 12, 2025 Amy Niles, chief mission officer, PAN Foundation, provides a deep dive into patient awareness of financial assistance…
DHL Officially Obtains CRYOPDP
Image Credit: Adobe Stock Images/Tippapatt.com Key Takeaways DHL has acquired Cryoport’s specialty courier business, CRYOPDP, for approximately $200 million, strengthening…
Using Data to Influence Drug Pricing Policy
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role…
The Financial Burden of Alzheimer’s Disease and Related Dementias
Image Credit: Adobe Stock Images/BeaunittaVanWyk.com Key Takeaways Alzheimer’s disease affects nearly 6.9 million older U.S. adults, making it the most…
Bridging Access Gaps
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role…
The Connection Between Virtual Care and Language Barriers
Image Credit: Adobe Stock Images/Nattakorn.com Key Takeaways Language barriers reduce access to video-based virtual care: Adult patients facing language barriers…
How MFN Executive Order Could Affect International Drug Costs
PC: Although ways to decrease healthcare costs are certainly encouraged by pharma supply chain stakeholders, what potential long-term repercussions (if…
Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season
Image Credit: Adobe Stock Images/Artur.com Key Takeaways Sanofi is shipping Beyfortus early to ensure strong supply for the 2025–2026 RSV…
Preparing for the Pharma C-Suite; America’s Vanishing Scientific Research Workforce is a Threat to Public Health
Preparing for the Pharma C-Suite In a Pharmaceutical Executive feature, Aileen Fernandes, Chief Business Officer at Arcellx, reflects on how…
Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them; Wegovy Use Up 50% Among US Teens
Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them In a Pharmaceutical Executive feature,…
Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization; Rethinking Clinical Trial Efficiency Amidst Cost Pressures on Pharma
Forging a Brighter Future for Rare Disease Outcomes with Specialty Pharmacy Utilization A Pharmaceutical Executive article explores how specialty pharmacy…
GLP-1 Drugs May be Linked to Elevated Risk of Serious Eye Disease; Incyte’s Zynyz Wins FDA Approval as Single and Combo Therapy for Anal Cancer
GLP-1 Drugs may be Linked to Elevated Risk of Serious Eye Disease, Study Finds A new observational study finds that…
Mapping the Hidden Costs
In a video interview with Pharma Commerce, Maggie McCullough, PolicyMap’s CEO, highlights how geospatial mapping can play a critical role…
The Variation in Dual-Eligible Beneficiary Characteristics across Medicare Advantage Plan Types
Image Credit: Adobe Stock Images/Wladimir1804.com Key Takeaways MA enrollment among full-benefit dual-eligible beneficiaries is rising, reaching nearly 50% by 2022.…